Official Publications PixarBio Corporation

Equities

Market Closed - OTC Markets Other stock markets 20:17:43 27/06/2023 BST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2018	PixarBio Corporation Clarifies Pathways to FDA Approval for NR14 to Treat “Trigeminal Neuralgia” and Post-Surgical Pain	CI
2018	Pixarbio Corporation Announces the Removal of Katrin Holzhaus as Chief Administration Officer and Corporate Secretary of the Company	CI

No official publication found